Naren Chaitya Pharma P.Ltd. Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Company Age 30 Year, 9 Months
- Open Charges ₹ 4.96 M
About Naren Chaitya Pharma P.Ltd.
Naren Chaitya Pharma P.Ltd. (NCPP) is a Private Limited Indian Non-Government Company incorporated in India on 26 April 1994 and has a history of 30 years and nine months. Its registered office is in Na, Maharashtra.
The Company is engaged in the Plastics Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.00.
The company currently has active open charges totaling ₹4.96 M.
Narendra Shah and Jyoti Shah serve as directors at the Company.
Company Details
- Location Na, Maharashtra
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U25209MH1994PTC077999
-
Company No.
077999
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
26 Apr 1994
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Naren Chaitya Pharma P.Ltd.?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Narendra Shah
|
Director | 26-Apr-1994 | Current |
|
Jyoti Shah
|
Director | 26-Apr-1994 | Current |
Financial Performance of Naren Chaitya Pharma P.Ltd..
Enhance accessibility to Naren Chaitya Pharma P.Ltd.'s financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Naren Chaitya Pharma P.Ltd.?
Unlock access to Naren Chaitya Pharma P.Ltd.'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Hiramani Agro Plantations Pvt LtdNarendra Shah and Jyoti Shah are mutual person
Charges (Loans)
₹4.96 M
₹0
Charges Breakdown by Lending Institutions
- Gujarat State Financial Corporation : 0.39 Cr
- Shri Arihant Co-Op;. Bank Ltd. : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Oct 1999 | Gujarat State Financial Corporation | ₹3.94 M | Open |
| 28 Nov 1996 | Shri Arihant Co-Op;. Bank Ltd. | ₹1.03 M | Open |
How Many Employees Work at Naren Chaitya Pharma P.Ltd.?
Unlock and access historical data on people associated with Naren Chaitya Pharma P.Ltd., such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Naren Chaitya Pharma P.Ltd., offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Naren Chaitya Pharma P.Ltd.'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.